Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
763.98 | -48,33% | -27,12% | 687.891,71 | 0,69% | 2,63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
910.00 | -1,79% | 18,59% | 4.053.901,21 | 1,03% | 18,5% |
|
NYSE:JNJ
Johnson & Johnson
|
151.38 | 0% | 0% | 364.323,09 | 3,28% | 2,71% |
|
NYSE:MRK
Merck
|
128.66 | -8,25% | 5,21% | 325.870,86 | 2,38% | -19,03% |
|
NYSE:ABBV
AbbVie
|
161.59 | -20,76% | -10,29% | 285.346,57 | 3,84% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
122.46 | 17,57% | 40,04% | 189.841,78 | 2% | 15,98% |
|
SWX:NOVN
Novartis
|
93.49 | 8,01% | 21,37% | 190.757,59 | 3,55% | 4,67% |
|
SWX:ROG
Roche Holding
|
224.60 | 32,32% | 48,46% | 181.258,38 | 4,21% | 0,43% |
|
NYSE:DHR
Danaher
|
259.26 | -18,55% | -7,74% | 192.030,39 | 0,42% | 10,89% |
|
NasdaqGS:AMGN
Amgen
|
311.41 | -11,96% | -3,14% | 167.051,13 | 2,92% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.38 | 9,41% | 39,92% | 160.817,91 | 5,91% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
91.69 | 16,05% | 34,5% | 114.488,32 | 4,06% | 8,19% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
428.59 | 1,69% | 9,74% | 110.599,1 | 0% | 30,14% |
|
NYSE:MDT
Medtronic
|
84.30 | 26,54% | 39,64% | 111.935,44 | 3,3% | 2,09% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
984.64 | -29,76% | -23,78% | 106.228,38 | 0% | 13,9% |
|
LSE:GSK
GSK
|
18.10 | 5,36% | 20,88% | 73.812,48 | 3,2% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.71 | 59,28% | 69,46% | 90.631,65 | 5,33% | 13,54% |
|
ASX:CSL
CSL
|
279.58 | 22,78% | 43,75% | 135.107,8 | 1,28% | 7,18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.65 | 21,02% | 30,29% | 84.281,97 | 4,56% | 0,15% |
|
NYSE:ZTS
Zoetis
|
168.87 | 31,02% | 47,24% | 77.054,56 | 1,03% | 11,19% |
